Philippe Mathurin
Mathurin, Philippe, 1962-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 214110014 ( Personal )
Permalink: http://viaf.org/viaf/214110014
Preferred Forms
-
100 1 _
‡a
Mathurin, Philippe
‡d
1962-...
-
100 1 _
‡a
Mathurin, Philippe,
‡d
1962-....
-
100 0 _
‡a
Philippe Mathurin
4xx's: Alternate Name Forms (2)
Works
| Title | Sources |
|---|---|
| [30] INVOLVEMENT OF NOD SIGNALLING IN HEPATOCYTE AND IMMUNE CELLS DURING HEPATITIS |
|
| Etude prospective de l'évolution lésionnelle hépatique (inflammation, ballonisation et fibrose) après chirurgie bariatrique des patients obèses morbides atteints de stéatopathie métabolique sévère et/ou de stéatohépatique |
|
| Evaluation des scores pronostiques de gravité en cas d’ACLF chez des patients cirrhotiques : étude prospective monocentrique |
|
| Evolution de la stéatose non alcoolique (NAFLD) chez des patients obèses traités chirurgicalement par anneau gastrique ou by-pass |
|
| [Hepatitis B viral infection treated with lamivudine during pregnancy]. |
|
| Influence pronostique de l'hépatite virale B ou C chez les patients transplantés rénaux |
|
| Intérêt d'un traitement anti-viral combiné dans la prise en charge des patients atteints d'hépatite B chronique |
|
| Is alcoholic hepatitis an indication for transplantation? Current management and outcomes. |
|
| L'évolution de la stéatose sévère après chirurgie de l'obésité est liée à l'insulino-résistance |
|
| The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. |
|
| L'INFLAMMATION DANS LA MALADIE ALCOOLIQUE DU FOIE : ETUDES CHEZ L'ANIMAL, ESSAIS CHEZ L'HOMME |
|
| Long-term results of percutaneous management for anastomotic biliary stricture after orthotopic liver transplantation |
|
| Main drivers of outcome differ between short and long-term in severe alcoholic hepatitis: A prospective study |
|
| Maladie de Still de l’adulte et angiosarcome hépatique, une association fortuite ou un syndrome paranéoplasique : à propos d’un cas |
|
| Management of alcohol dependence in transplant candidates: we are far away from the objective line. |
|
| Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis. |
|
| [Membranous glomerulonephritis complicating hepatocellular carcinoma] |
|
| Mésaventure au paracétamol et exacerbation de la toxicité en cas de surdosage chez le buveur excessif : deux entités controversées |
|
| Mesenteric adenitis and portal vein thrombosis due to Fusobacterium nucleatum. |
|
| micro-Opioid receptor activation prevents acute hepatic inflammation and cell death |
|
| MISE AU POINT DE L'AMPLIFICATION GENIQUE COMPETITIVE POUR LA QUANTIFICATION DES TRANSCRITS DES APOLIPOPROTEINES AI ET AII CHEZ LE BUVEUR EXCESSIF |
|
| Mise en évidence de deux nouvelles fonctions du système endocannabinoïde dans la physiopathologie de la stéatose hépatique : propriétés stéatogènes du récepteur CB2 et profibrogéniques du récepteur CB1 |
|
| Le modèle de Lille : un nouvel outil pour prédire la survie à 6 mois des patients présentant une hépatite alcoolique sévère traités par corticoïdes |
|
| Modélisation de la morbi-mortalité du carcinome hépatocellulaire en France par stade de gravité : évaluation de différentes stratégies en fonction du dépistage et des ressources thérapeutiques |
|
| Modélisation de la stéatose hépatique (NAFLD) et de ses facteurs de risque par apprentissage sur des données de santé |
|
| Modelling of hepatic steatosis (NAFLD) and its risk factors by learning from health data. |
|
| Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding. |
|
| Mycophenolate mofetil monotherapy for severe side effects of calcineurin inhibitors following liver transplantation. |
|
| The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. |
|
| Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 control. |
|
| NOD2: a potential target for regulating liver injury. |
|
| Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir). |
|
| [Nuclear receptor PPAR and hepatology: pathophysiological and therapeutical aspects]. |
|
| Optimisation du traitement de l'hépatite alcoolique sévère et identification d'une nouvelle cible thérapeutique : le récepteur CB2 des cannabinoïdes |
|
| [Overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis] |
|
| Partial graft recovery following eradication of hepatitis E virus infection after successful islet allograft transplantation. |
|
| Peroxisome proliferator-activated receptors in HBV-related infection |
|
| Perspectives on Treatment for Nonalcoholic Steatohepatitis |
|
| Phase II trial of docetaxel therapy in patients with advanced hepatocellular carcinoma |
|
| Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis |
|
| Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. |
|
| Prevalence of Cholelithiasis According to Alcoholic Liver Disease: A Possible Role of Apolipoproteins AI and AII |
|
| Prevalence of renal abnormalities in chronic HBV infection: the HARPE study. |
|
| Primary sarcoma of the liver and transplantation: a case study and literature review |
|
| Prise en charge chirurgicale de l'obèse et de l'obèse morbide : conséquences sur la stéatopathie métabolique et sur l'accès à la transplantation hépatique |
|
| Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis |
|
| Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis |
|
| Prospective analysis of aneurysm treatment in a series of 103 consecutive patients when endovascular embolization is considered the first option |
|
| Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. |
|
| Prothrombin index decrease: a useful and reliable marker of extensive fibrosis? |
|
| Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease. |
|
| Randomised clinical trial: enteral nutrition does not improve the long-term outcome of alcoholic cirrhotic patients with jaundice |
|
| Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin. |
|
| Recalibrated MELD and hepatic encephalopathy are prognostic factors in cirrhotic patients with acute variceal bleeding. |
|
| Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complication. |
|
| La réduction précoce de la charge virale peut prédire la réponse virologique des patients VHC génotypes non-2 non-3 non répondeurs retraités par bithérapie pegylée |
|
| Relationship between the hepatitis C viral load and the serum interferon concentration during the first week of peginterferon-alpha-2b-ribavirin combination therapy. |
|
| Relevance of the ISGLS definition of posthepatectomy liver failure in early prediction of poor outcome after liver resection: study on 680 hepatectomies. |
|
| Reply: To PMID 24677195 |
|
| Rôle des composés bactériens et de NOD 2 dans la cellule myofibroblastique hépatique |
|
| Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study |
|
| Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients. |
|
| Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score |
|
| Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B. |
|
| Shortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: a meta-analysis. |
|
| Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141). |
|
| Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. |
|
| La stéatose hépatique métabolique vue par le médecin généraliste |
|
| Surgical clipping may lead to better results than coil embolization: results from a series of 101 consecutive unruptured intracranial aneurysms |
|
| Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. |
|
| [Therapeutic misadventure with acetaminophen in alcoholics]. |
|
| Tolérance et efficacité du système MARS® chez les patients présentant une hépatite alcoolique sévère non répondeurs aux corticoïdes : une étude pilote |
|
| A tool to predict progression of non-alcoholic fatty liver disease in severely obese patients |
|
| Towards a better understanding of alcohol-related liver disease and the factors influencing its progression : a modeling approach. |
|
| Transforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon |
|
| Transvascular coil hooking procedure to retrieve an unraveled Guglielmi detachable coil: technical note. |
|
| Treatment of chronic hepatitis C by interferon for longer duration than six months |
|
| Trends in the management and burden of alcoholic liver disease. |
|
| Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities |
|
| Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites |
|
| The use of corticosteroids in severe alcohol hepatitis: we need to look beyond this controversy. |
|
| Usefulness of routine analysis of ascitic fluid at the time of therapeutic paracentesis in asymptomatic outpatients. Results of a multicenter prospective study. |
|
| Valeur pronostique du meld dans les hémorragies digestives du cirrhotique |
|
| Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity |
|
| Vers une meilleure compréhension de la maladie du foie liée à l'alcool et des facteurs influençant sa progression : approche de modélisation |
|
| Vialebex 200 mg/ml : albumine humaine : cas cliniques n° 3 |
|
| প্রত্যুত্তর |
|
